These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8109847)

  • 61. Myoblast allotransplantation in mice: degree of success varies depending on the efficacy of various immunosuppressive treatments.
    Vilquin JT; Asselin I; Guérette B; Kinoshita I; Lille S; Roy R; Tremblay JP
    Transplant Proc; 1994 Dec; 26(6):3372-3. PubMed ID: 7998179
    [No Abstract]   [Full Text] [Related]  

  • 62. Short-term immunosuppression after rat parathyroid allotransplantation.
    Timm S; Otto C; Begrich D; Illert B; Hamelmann W; Ulrichs K; Thiede A; Timmermann W
    Microsurgery; 2003; 23(5):503-7. PubMed ID: 14558011
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rapamycin effects on immunologic reconstitution.
    Vogelsang GB; Hess AD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):727-8. PubMed ID: 8438459
    [No Abstract]   [Full Text] [Related]  

  • 64. The effect of cyclosporin A on experimental pancreas allografts in the rat.
    Garvey JF; McShane P; Poole MD; Millard PR; Morris PJ
    Transplant Proc; 1980 Jun; 12(2):266-9. PubMed ID: 6771902
    [No Abstract]   [Full Text] [Related]  

  • 65. Azathioprine does not potentiate the immunosuppressive effect of 15-deoxyspergualin in rat heart allografting.
    Gannedahl G; Wanders A; Wadström J; Olausson M; Ekberg H; Tufveson G
    Transplant Proc; 1994 Dec; 26(6):3108-10. PubMed ID: 7998085
    [No Abstract]   [Full Text] [Related]  

  • 66. Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation.
    Tanabe M; Todo S; Murase N; Irish W; Miyazawa H; Fujisaki S; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):364-5. PubMed ID: 7533411
    [No Abstract]   [Full Text] [Related]  

  • 67. Rapamycin: immunosuppression, hyporesponsiveness, and side effects in a porcine renal allograft model.
    Almond PS; Moss A; Nakhleh RE; Melin M; Chen S; Salazar A; Shirabe K; Matas AJ
    Transplantation; 1993 Aug; 56(2):275-81. PubMed ID: 8356580
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pretreatment of donors and grafts with rapamycin: the effect on graft survival and the tissue drug retention.
    Chen H; Sehgal S; Daloze P; Wu J
    Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):321-3. PubMed ID: 7554455
    [No Abstract]   [Full Text] [Related]  

  • 69. Triple combination of cyclosporine, brequinar, and rapamycin prolongs kidney allograft survival in the mongrel dog.
    Ferraresso M; Knight R; Tu Y; Stepkowski SM; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3028. PubMed ID: 7940953
    [No Abstract]   [Full Text] [Related]  

  • 70. Effect of splenectomy and mono- or combination therapy with rapamycin, the morpholinoethyl ester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival.
    Wang J; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):699-702. PubMed ID: 1990655
    [No Abstract]   [Full Text] [Related]  

  • 71. Ascorbic acid and alpha-tocopherol prolong rat cardiac allograft survival.
    Slakey D; Roza A; Pieper G; Johnson C; Adams M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):610-1. PubMed ID: 8438434
    [No Abstract]   [Full Text] [Related]  

  • 72. Tyrphostin AG490 selectively inhibits activation of the JAK3/STAT5/MAPK pathway and rejection of rat heart allografts.
    Kirken RA; Erwin-Cohen R; Behbod F; Wang M; Stepkowski SM; Kahan BD
    Transplant Proc; 2001; 33(1-2):95. PubMed ID: 11266723
    [No Abstract]   [Full Text] [Related]  

  • 73. Rapamycin suppression of host-versus-graft and graft-versus-host disease in MHC-mismatched rats.
    Fabian MA; Denning SM; Bollinger RR
    Transplant Proc; 1992 Jun; 24(3):1174. PubMed ID: 1604575
    [No Abstract]   [Full Text] [Related]  

  • 74. Sirolimus-mediated prolongation of rat cardiac allograft survival is enhanced by beta1 integrin very late antigen-4 blockade.
    Vu MD; Qi S; Sehgal SN; Chen H; Kennedy JD
    Transplant Proc; 2005; 37(1):162-3. PubMed ID: 15808581
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of immunosuppressive drugs (CsA, FK 506, rapamycin) on the kidney microsomal cytochrome P-450 system in the rat.
    Yoshimura R; Yoshimura N; Ohmachi T; Nakatani T; Ohyama A; Miyao Y; Yamamoto K; Kishimoto T
    Transplant Proc; 1994 Oct; 26(5):2890. PubMed ID: 7524223
    [No Abstract]   [Full Text] [Related]  

  • 76. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats.
    Ferraresso M; Tian L; Ghobrial R; Stepkowski SM; Kahan BD
    J Immunol; 1994 Oct; 153(7):3307-18. PubMed ID: 8089500
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
    Wasowska B; Wieder KJ; Hancock WW; Zheng XX; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
    J Immunol; 1996 Jan; 156(1):395-404. PubMed ID: 8598490
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Survival of cardiac allografts in rats treated with cyclosporin A.
    Jamieson SW; Burton NA; Bieber CP; Reitz BA; Oyer PE; Stinson EB; Shumway NE
    Surg Forum; 1979; 30():289-91. PubMed ID: 395684
    [No Abstract]   [Full Text] [Related]  

  • 79. Cardiac allograft tolerance induction with limited immunosuppression.
    Cohen DS; Fisher RA; Tarry WC; Tawes JW
    J Surg Res; 1996 Mar; 61(2):355-60. PubMed ID: 8656608
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation.
    Candinas D; Achilleos O; Lee SJ; Dalgic A; Mayer AD; Buckels JA; McMaster P; D'Silva M
    Transplant Proc; 1994 Dec; 26(6):3251-2. PubMed ID: 7527959
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.